A statistical and learning based oncogene detection and classification scheme using human cDNA expressions for ovarian carcinoma

Expert Systems with Applications

Volumn 38, Issue 8, 2011, Pages 10066-10074

  Tsai, Meng Hsiun ^a   Lai, Ching Hao ^b   Yu, Shyr Shen ^a  

^a NATIONAL CHUNG HSING UNIVERSITY   (Taiwan)

^b INSTITUTE FOR INFORMATION INDUSTRY   (Taiwan)

Author keywords

Artificial neural network (ANN); cDNA; Gene expression analysis; Microarray database; Oncogenes; Ovarian cancer; t Test

Indexed keywords

ARTIFICIAL NEURAL NETWORK; CDNA; GENE EXPRESSION ANALYSIS; MICROARRAY DATABASE; ONCOGENES; OVARIAN CANCERS; T-TEST;

DATABASE SYSTEMS; DISEASES; GRAPHICAL USER INTERFACES; NEURAL NETWORKS; ONCOGENIC VIRUSES;

GENE EXPRESSION;

EID: 79953688971     PISSN: 09574174     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eswa.2011.02.010     Document Type: Article

References (62)

1. A.A. Alizadeh, M.B. Eisen, and R.E. Davis Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling Nature 2000 503 511 (Pubitemid 30082188)
2. K. Ansenberger, Y. Zhuge, J.A. Lagman, C. Richards, A. Barua, and J.M. Bahr E-cadherin expression in ovarian cancer in the laying hen, Gallus domesticus, compared to human ovarian cancer Gynecologic Oncology 113 3 2009 362 369
3. P. Athanassiadou, D. Grapsa, P. Athanassiades, M. Gonidi, A.M. Athanassiadou, and A. Tsipis The prognostic significance of COX-2 and surviving expression in ovarian cancer Pathology, Research and Practice 204 4 2008 241 249 (Pubitemid 351377530)
4. V. Barak, U. Elchalal, M. Edelstein, I. Kalickman, A. Lewin, and Y. Abramov Interleukin-18 levels correlate with severe ovarian hyperstimulation syndrome Fertility and Sterility 82 2 2004 415 420 (Pubitemid 39092043)
5. F. Bartel, J. Jung, A. Böhnke, E. Gradhand, K. Zeng, and C. Thomssen Both germ line and somatic genetics of the p53 pathway affect ovarian cancer incidence and survival Clinical Cancer Research 14 1 2008 89 96 (Pubitemid 351377982)
6. D. Belotti, P. Paganoni, L. Manenti, A. Garofalo, S. Marchini, and G. Taraboletti Matrix metalloproteinases (MMP9 and MMP2) induce the release of vascular endothelial growth factor (VEGF) by ovarian carcinoma cells: Implications for ascites formation Cancer Research 63 17 2003 5224 5229 (Pubitemid 37139832)
7. L. Bingle, V. Singleton, and C.D. Bingle The putative ovarian tumour marker gene HE4 (WFDC2) is expressed in normal tissues and undergoes complex alternative splicing to yield multiple protein isoforms Oncogene 21 2002 2768 2773 (Pubitemid 34478335)
8. J.L. Brun, A. Cortez, F. Commo, S. Uzan, R. Rouzier, and E. Daraï Serous and mucinous ovarian tumors express different profiles of MMP-2, -7, -9, MT1-MMP, and TIMP-1 and -2 International Journal of Oncology 33 6 2008 1239 1246
9. H. Camlica, D. Duranyildiz, F. Tas, and V. Yasasever Statistical interpretation of CA125 and Bcl-2 in serum of patients with late stage ovarian cancer American Journal of Clinical Oncology 31 6 2008 585 588
10. K.D. Cowden Dahl, J. Symowicz, Y. Ning, E. Gutierrez, D.A. Fishman, and B.P. Adley Matrix metalloproteinase 9 is a mediator of epidermal growth factor-dependent e-cadherin loss in ovarian carcinoma cells Cancer Research 68 12 2008 4606 4613
11. C. Denkert, W. Weichert, S. Pest, I. Koch, D. Licht, and M. Köbel Overexpression of the embryonic-lethal abnormal vision-like protein HuR in ovarian carcinoma is a prognostic factor and is associated with increased cyclooxygenase 2 expression Cancer Research 64 1 2004 189 195 (Pubitemid 38114097)
12. J. DeRisi, L. Penland, P.O. Brown, M.L. Bittner, P.S. Meltzer, and M. Ray Use of a cDNA microarray to analyze gene expression patterns in human cancer Nature Genetics 14 1996 457 460 (Pubitemid 26414590)
13. T.V. Do, L.A. Kubba, M. Antenos, A.W. Rademaker, C.D. Sturgis, and T.K. Woodruff The role of activin A and Akt/GSK signaling in ovarian tumor biology Endocrinology 149 8 2008 3809 3816
14. Eickhoff, B.; Ruller, S.; Laue, T.; Kohler, G.; Stahl, C.; Schlaak, M.; et al. (2000). T Trichostatin A modulates expression of p21waf1/cip1, Bcl-xL, ID1, ID2, ID3, CRAB2, GATA-2, hsp86 and TFIID/TAFII31 mRNA in human lung adenocarcinoma cells. Biological Chemistry 381, 107-112.
15. Feng, Q.; Deftereos, G.; Hawes, S. E.; Stern, J. E.; Willner, J. B.; Swisher, E. M.; et al. DNA hypermethylation, Her-2/neu overexpression and p53 mutations in ovarian carcinoma. Gynecologic Oncology, 111(2), 320-329.
16. R.A. Fisher Applications of "student's" distribution Metron 5 1925 90 104
17. Gabriel, B.; Mildenberger, S.; Weisser, C. W.; Metzger, E.; Gitsch, G.; Schüle, R.; et al. Focal adhesion kinase interacts with the transcriptional coactivator FHL2 and both are overexpressed in epithelial ovarian cancer. Anticancer Research 24(2B), 921-927.
18. G. Gutman, L. Soussan-Gutman, M. Malcov, J.B. Lessing, A. Amit, and F. Azem Interleukin-18 is high in the serum of IVF pregnancies with ovarian hyperstimulation syndrome American Journal of Reproductive Immunology 51 5 2004 381 384 (Pubitemid 38765273)
19. V.A. Heinzelmann-Schwarz, M. Gardiner-Garden, S.M. Henshall, J. Scurry, R.A. Scolyer, and M.J. Davies Overexpression of the cell adhesion molecules DDR1, Claudin 3, and Ep-CAM in metaplastic ovarian epithelium and ovarian cancer Clinical Cancer Research 10 13 2004 4427 4436 (Pubitemid 38878885)
20. I. Hellstrom, J. Raycraft, M. Hayden-Ledbetter, J.A. Ledbetter, M. Schummer, and M. McIntosh The HE4 (WFDC2) protein is a biomarker for ovarian carcinoma Cancer Research 63 2003 3695 3700 (Pubitemid 36793054)
21. E.V. Høgdall, L. Christensen, C.K. Høgdall, K. Frederiksen, S. Gayther, and J. Blaakaer Distribution of p53 expression in tissue from 774 Danish ovarian tumour patients and its prognostic significance in ovarian carcinomas APMIS 116 5 2008 400 409 (Pubitemid 351623871)
22. G.S. Huang, Y.C. Hung, A. Chen, and M.Y. Hong Microarray analysis of ovarian cancer IEEE International Conference on Systems, Man and Cybernetics 2 2005 1036 1041 (Pubitemid 41667442)
23. L.G. Hudson, N.M. Moss, and M.S. Stack EGF-receptor regulation of matrix metalloproteinases in epithelial ovarian carcinoma Future Oncology 5 3 2009 323 338
24. S. Inan, S. Vatansever, C. Celik-Ozenci, M. Sanci, N. Dicle, and R. Demir Immunolocalizations of VEGF, its receptors flt-1, KDR and TGF-beta's in epithelial ovarian tumors Histology and Histopathology 21 10 2006 1055 1064 (Pubitemid 44614486)
25. R.S. Ismail, R.L. Baldwin, J. Fang, D. Browning, B.Y. Karlan, and J.C. Gasson Differential gene expression between normal and tumor-derived ovarian epithelial cells Cancer Research 60 2000 6744 6749
26. A. Jemal, A. Thomas, T. Murray, and M. Thun Cancer statistics CA: A Cancer Journal for Clinicians 52 2002 23 47
27. K.J. Jeong, S.Y. Park, J.H. Seo, K.B. Lee, W.S. Choi, and J.W. Han Lysophosphatidic acid receptor 2 and Gi/Src pathway mediate cell motility through cyclooxygenase 2 expression in CAOV-3 ovarian cancer cells Experimental and Molecular Medicine 40 6 2008 607 616
28. H.A. Kenny, S. Kaur, L.M. Coussens, and E. Lengyel The initial steps of ovarian cancer cell metastasis are mediated by MMP-2 cleavage of vitronectin and fibronectin Journal of Clinical Investigation 118 4 2008 1367 1379 (Pubitemid 351500430)
29. H.A. Kenny, and E. Lengyel MMP-2 functions as an early response protein in ovarian cancer metastasis Cell Cycle 18 5 2009 683 688
30. P. Korkolopoulou, I. Vassilopoulos, A.E. Konstantinidou, H. Zorzos, E. Patsouris, and E. Agapitos The combined evaluation of p27Kip1 and Ki-67 expression provides independent information on overall survival of ovarian carcinoma patients Gynecologic Oncology 85 3 2002 404 414 (Pubitemid 34651877)
31. C.H. Lai, S.S. Yu, J.D. Chang, and M.H. Tsai Statistical and SVM-based oncogene detection of human cDNA expressions for ovarian carcinoma International Journal of Innovative Computing, Information and Control 5 10A 2009 3157 3177
32. K. Li, M. Mandai, J. Hamanishi, N. Matsumura, A. Suzuki, and H. Yagi Clinical significance of the NKG2D ligands, MICA/B and ULBP2 in ovarian cancer: high expression of ULBP2 is an indicator of poor prognosis Cancer Immunology, Immunotherapy 58 5 2009 641 652
33. A.J. Li, D.R. Scoles, K.U. Armstrong, and B.Y. Karlan Androgen receptor cytosine-adenine-guanine repeat polymorphisms modulate EGFR signaling in epithelial ovarian carcinomas Gynecologic Oncology 109 2 2008 220 225
34. Z. Liguang, L. Peishu, M. Hongluan, J. Hong, W. Rong, and M.S. Wachtel Surviving expression in ovarian cancer Experimental Oncology 29 2 2007 121 125
35. C.K. Lin, H.Y. Su, W.C. Tsai, L.F. Sheu, and J.S. Jin Association of cortactin, fascin-1 and epidermal growth factor receptor (EGFR) expression in ovarian carcinomas: correlation with clinicopathological parameters Disease Markers 25 1 2008 17 26
36. C.G. Looney Pattern recognition using neural networks: Theory and algorithms for engineers and scientists 1997 Oxford University Press
37. P.L. Lorenzi, J. Llamas, M. Gunsior, L. Ozbun, W.C. Reinhold, and S. Varma Asparagine synthetase is a predictive biomarker of l-asparaginase activity in ovarian cancer cell lines Molecular Cancer Therapeutics 7 10 2008 3123 3128
38. A.M. Martoglio, B.D. Tom, M. Starkey, A.N. Corps, D.S. Charnock-Jones, and S.K. Smith Changes in tumorigenesis- and angiogenesis-related gene transcript abundance profiles in ovarian cancer detected by tailored high density cDNA arrays Molecular Medicine 6 2000 750 765
39. Moreno, M.; Bontkes, H. J.; Scheper, R. J.; Kenemans, P.; Verheijen, R. H.; von Mensdorff-Pouilly, S. (2007). High level of MUC1 in serum of ovarian and breast cancer patients inhibits huHMFG-1 dependent cell-mediated cytotoxicity (ADCC). Cancer Letters, 257(1), 47-55. Epub 2007 Aug 9.
40. T. Okamoto, R. Niu, and S. Yamada Increased expression of tissue inhibitor of metalloproteinase-2 in clear cell carcinoma of the ovary Molecular Human Reproduction 9 10 2003 569 575 (Pubitemid 37220816)
41. K. Ono, T. Tanaka, T. Tsunoda, O. Kitahara, C. Kihara, and A. Okamoto Identification by cDNA microarray of genes involved in ovarian carcinogenesis Cancer Research 60 2000 5007 5011
42. J.E. Palmer, L.J. Sant Cassia, C.J. Irwin, A.G. Morris, and T.P. Rollason P53 and bcl-2 assessment in serous ovarian carcinoma International Journal of Gynecological Cancer 18 2 2008 241 248 (Pubitemid 351365201)
43. E. Pau, I. Alonso-Muriel, R. Gómez, E. Novella, A. Ruiz, and J.A. García-Velasco Plasma levels of soluble vascular endothelial growth factor receptor-1 may determine the onset of early and late ovarian hyperstimulation syndrome Human Reproduction 21 6 2006 1453 1460 (Pubitemid 44445021)
44. Y.L. Pon, and A.S. Wong Gonadotropin-induced apoptosis in human ovarian surface epithelial cells is associated with cyclooxygenase-2 up-regulation via the beta-catenin/T-cell factor signaling pathway Molecular Endocrinology 20 12 2006 3336 3350 (Pubitemid 44833574)
45. Pongsavee, M.; Yamkamon, V.; Dakeng, S.; O-charoenrat, P.; Smith, D. R.; Saunders, G. F.; et al. (2009). The BRCA1 3'-UTR: 5711+421T/T-5711+1286T/T genotype is a possible breast and ovarian cancer risk factor. Genetic Testing and Molecular Biomarkers, 13(3), 307-317.
46. N.V. Porhanova, A.P. Sokolenko, N.Y. Sherina, D.N. Ponomariova, N.N. Tkachenko, and D.E. Matsko Ovarian cancer patient with germline mutations in both BRCA1 and NBN genes Cancer Genetics and Cytogenetics 186 2 2008 122 124
47. S.J. Ramus, and S.A. Gayther The contribution of BRCA1 and BRCA2 to ovarian cancer Molecular Oncology 3 2 2009 138 150
48. K. Rask, A. Nilsson, M. Brännström, P. Carlsson, P. Hellberg, and P.O. Janson Wnt-signalling pathway in ovarian epithelial tumours: increased expression of beta-catenin and GSK3beta British Journal of Cancer 89 7 2003 1298 1304 (Pubitemid 37363420)
49. M. Schena, D. Shalon, R.W. Davis, and P.O. Brown Quantitative monitoring of gene expression patterns with a complementary DNA microarray Science 270 1995 467 470
50. J.M. Schildkraut, E.L. Goode, M.A. Clyde, E.S. Iversen, P.G. Moorman, and A. Berchuck Single nucleotide polymorphisms in the TP53 region and susceptibility to invasive epithelial ovarian cancer Cancer Research 69 6 2009 2349 2357
51. M. Schummer, W.V. Ng, R.E. Bumgarner, P.S. Nelson, B. Schummer, and D. Bednarski Comparative hybridization of an array of 21,500 ovarian cDNAs for the discovery of genes overexpressed in ovarian carcinomas Gene 238 1999 375 385 (Pubitemid 29446174)
52. I.S. Serin, F. Tanriverdi, M.O. Yilmaz, B. Ozcelik, and K. Unluhizarci Serum insulin-like growth factor (IGF)-I, IGF binding protein (IGFBP)-3, leptin concentrations and insulin resistance in benign and malignant epithelial ovarian tumors in postmenopausal women Gynecological Endocrinology 24 3 2008 117 121 (Pubitemid 351365853)
53. V. Smith, S. Hobbs, W. Court, S. Eccles, P. Workman, and L.R. Kelland ErbB2 overexpression in an ovarian cancer cell line confers sensitivity to the HSP90 inhibitor geldanamycin Anticancer Research 22 4 2002 1993 1999 (Pubitemid 34857015)
54. Spinella, F.; Rosan, L.; Elia, G.; Di Castro, V.; Natali, P. G.; Bagnato, A. (2004). Endothelin-1 stimulates cyclooxygenase-2 expression in ovarian cancer cells through multiple signaling pathways: evidence for involvement of transactivation of the epidermal growth factor receptor. Journal of Cardiovascular Pharmacology, 44 (Suppl 1:S140-3).
55. Spinella, F.; Rosan, L.; Elia, G.; Di Castro, V.; Natali, P. G.; Bagnato, A. (2004). Endothelin-1 stimulates cyclooxygenase-2 expression in ovarian cancer cells through multiple signaling pathways: evidence for involvement of transactivation of the epidermal growth factor receptor. Journal of Cardiovascular Pharmacology, 44(Suppl. 1), S140-S143.
56. Steffensen, K. D.; Waldstrøm, M.; Olsen, D. A.; Corydon, T.; Lorentzen, K. A.; Knudsen, H. J.; et al. Mutant epidermal growth factor receptor in benign, borderline, and malignant ovarian tumors. Clinical Cancer Research 14(11), 3278-3282.
57. K. Wang, L. Gan, E. Jeffery, M. Gayle, A.M. Gown, and M. Skelly Monitoring gene expression profile changes in ovarian carcinomas using cDNA microarray Gene 229 1999 101 108 (Pubitemid 29148312)
58. S.W. Warrenfeltz, S.A. Lott, T.M. Palmer, J.C. Gray, and D. Puett Luteinizing hormone-induced up-regulation of ErbB-2 is insufficient stimulant of growth and invasion in ovarian cancer cells Molecular Cancer Research 6 11 2008 1775 1785
59. Weberpals, J.; Garbuio, K.; O'Brien, A.; Clark-Knowles, K.; Doucette, S.; Antoniouk, O.; et al. The DNA repair proteins BRCA1 and ERCC1 as predictive markers in sporadic ovarian cancer. International Journal of Cancer, 124(4), 806-815.
60. J.B. Welsh, P.P. Zarrinkar, L.M. Sapinoso, S.G. Kern, C.A. Behling, and B.J. Monk Analysis of gene expression profiles in normal and neoplastic ovarian tissue samples identifies candidate molecular markers of epithelial ovarian cancer Proceedings of the National Academy of Sciences of the United States of America 98 2001 1176 1181 (Pubitemid 32121206)
61. L.H. Williams, D. Choong, S.A. Johnson, and I.G. Campbell Genetic and epigenetic analysis of CHEK2 in sporadic breast, colon, and ovarian cancers Clinical Cancer Research 12 23 2006 6967 6972 (Pubitemid 44974490)
62. C. Wu, J. Cipollone, S. Maines-Bandiera, C. Tan, A. Karsan, and N. Auersperg The morphogenic function of E-cadherin-mediated adherens junctions in epithelial ovarian carcinoma formation and progression Differentiation 76 2 2008 193 205 (Pubitemid 351197172)